Skip to main content
search
Fact Sheet

Model-Based Meta-Analysis (MBMA) for Drug Development Decision Support

Skip to PDF content

Make more confident development decisions with MBMA

Explore how Certara’s MBMA experts combine quantitative modeling with curated clinical outcomes data to benchmark therapies, optimize development strategies, and generate decision-ready evidence across the drug development lifecycle.

Explore MBMA Services Talk to an MBMA Expert

You May Also Like

De-Risking Phase 3 Rheumatoid Arthritis Trials with Model-Based Meta-Analysis (MBMA)
De-Risking Phase 3 Rheumatoid Arthritis Trials with Model-Based Meta-Analysis (MBMA)Case Study

De-Risking Phase 3 Rheumatoid Arthritis Trials with Model-Based Meta-Analysis (MBMA)

Model-Based Meta-Analysis (MBMA): Real-World Examples
Model-Based Meta-Analysis (MBMA): Real-World ExamplesFact Sheet

Model-Based Meta-Analysis (MBMA): Real-World Examples

MBMA data curation: How AI and expert meta-analysts get it right, fast
MBMA data curation: How AI and expert meta-analysts get it right, fastBlog

MBMA data curation: How AI and expert meta-analysts get it right, fast